Body Clinical Gallery
Cartesion Prime
Canon Medical is on the forefront of Deep Learning Reconstruction (DLR) development for medical imaging, as evident by the successful release of Advanced intelligent Clear-IQ Engine (AiCE) for CT and MR. And now, AiCE for PET is available on Cartesion Prime to help clinicians achieve PET images with improved image quality under a wide variety of imaging conditions.
Body
Hodgkin’s Lymphoma, AiCE for PET
Cartesion Prime
Low dose F-18 FDG PET with Advanced Intelligent Clear IQ Engine demonstrates increased number of FDG avid lesions. Biopsy proven lymphoma.
AiCE for PET Features:
- Image quality: Improved SNR
- Quantification accuracy: Improvement in contrast at the same noise level1
- Count dependency: Reduction in counts while preserving SNR
| PET | |
| Injected Dose | 7.6 mCi FDG |
| Uptake Time | 62 min |
| Patient BMI | 19.5 |
| Time Per Bed | 120 sec |
| Total Scan Time | 12 min |
| Recon | |
| TOF | ON |
| PSF | ON |
| Iterations/Subsets | N/A |
| Post-filter | N/A |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
Body
Lung Cancer, BMI 39.2, AiCE for PET
Cartesion Prime
Lung Carcinoma. Low dose CT and PET images were acquired on a Canon Cartesion digital PET-CT scanner. The Cartesion digital PET-CT system uses 1:1 coupling and AiCE Deep Learning Reconstruction. AiCE DLR provides a boost in signal and increased contrast, making it easier to see smaller lesions.
View Scan Parameters| PET | |
| Injected Dose | 7.2 mCi |
| Uptake Time | 54 min |
| Patient Height | 5’1” |
| Patient BMI | 39.2 |
| TOF | ON |
| Time per Bed | 120 sec |
| Total Scan Time | 10 min |
| Recon |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
Body
Prostate, Total Body PSMA Pylarify
(Piflufolastat F-18)
Cartesion Prime
Total body PSMA F-18 Pylarify scan using variable bedtime, Time-of-flight (TOF) and Point Spread Function (PSF).
Images show recurrent and metastatic lesions.
View Scan Parameters| PET | |
| Injected Dose | 9.6 mCi F-18 Pylarify |
| Uptake Time | 60 min |
| Patient BMI | 29.3 |
| Time per Bed | 6/120 sec 5/60 sec |
| Total Scan Time | 17 min |
| Recon | 3D OSEM |
| TOF | ON |
| PSF | ON |
| Iterations/Subsets | 4 iterations 12 subsets |
| Post-filter | Gaussian 6.0 mm |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
Body
Prostate, PSMA Pylarify (Piflufolastat F-18)
Cartesion Prime
PSMA scan using F-18 Pylarify shows recurrent prostate malignancy with retroperitoneal and presacral metastatic nodes.
PSMA Pylarify is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
View Scan Parameters| PET | |
| Injected Dose | 9.7 mCi F-18 Pylarify |
| Uptake Time | 60 min |
| Patient BMI | 29.0 |
| Time per Bed | 120 sec |
| Total Scan Time | 10 min |
| Recon | 3D OSEM |
| TOF | ON |
| PSF | ON |
| Iterations/Subsets | 4 iterations 12 subsets |
| Post-filter | Gaussian 6.0 mm |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
Body
Prostate, PSMA Ga-68
Cartesion Prime
Ga-68 PSMA scan. Malignant neoplasm of prostate with increased PSA.
PSMA scan obtained from vertex to thighs show a hypermetabolic osteoblastic lesion of lumbar spine.
View Scan Parameters| PET | |
| Injected Dose | 5.05 mCi Ga-68 |
| Uptake Time | 60 min |
| Patient BMI | 29.7 |
| Time per Bed | 2/240 sec 4/120 sec |
| Total Scan Time | 16 min |
| Recon | 3D OSEM |
| TOF | ON |
| PSF | ON |
| Iterations/Subsets | 4 iterations 12 subsets |
| Post-filter | Gaussian 6.0 mm |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
Body
Cu-64 Dotatate, Neuroendocrine Tumor
Cartesion Prime
Cu-64 Dotatate exam was performed on the Cartesion Prime digital PET/CT and reconstructed using Time-of-Flight and PSF.
True Time-of-flight (TOF) PET with point spread function (PSF) reconstruction aids in the detection of small lesions.
Cu-64 Dotatate is used for localization of somatostatin receptor (SSTR) positive neuroendocrine tumors (NETs).
Scan demonstrates small lesion in the right upper neck, multiple hepatic metastatic lesions as well as metastatic lesion at the lumbosacral junction.
View Scan Parameters| PET | |
| Injected Dose | 4.0 mCi Cu-64 |
| Uptake Time | 61 min |
| Patient BMI | 23 |
| Time per Bed | 180 sec |
| Total Scan Time | 18 min |
| Recon | 3D OSEM |
| TOF | ON |
| PSF | ON |
| Iterations/Subsets | 4 iterations 12 subsets |
| Post-filter | Gaussian 6.0 mm |
Clinical results are the experience of the facility. Results may vary due to clinical setting, patient presentation and other factors.
